摘要
B y comparing all gene-coding sequences in the genome between tumors and matched normal samples from clinically localized and castration-resistant （CR） prostate cancer patients, two groups of scien- tists have recently identified more than 5000 somatic mutations.
B y comparing all gene-coding sequences in the genome between tumors and matched normal samples from clinically localized and castration-resistant （CR） prostate cancer patients, two groups of scien- tists have recently identified more than 5000 somatic mutations.
